NASDAQ:HALO | Operating Income | HALOZYME THERAPEUTICS, INC.

Complete source-backed operating income history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30$287.65M
2026-03-31$184.52M
2025-12-31-$92.89M
2025-09-30$217.92M
2025-06-30$202.44M
2025-03-31$141.54M
2024-12-31$175.5M
2024-09-30$163.2M
2024-06-30$117.24M
2024-03-31$95.54M
2023-12-31$101.04M
2023-09-30$88.28M
2023-06-30$94.46M
2023-03-31$53.8M
2022-12-31$74.51M
2022-09-30$83.29M
2022-06-30$34.06M
2022-03-31$75.67M
2021-12-31$56.53M
2021-09-30$75.59M
2021-06-30$93.05M
2021-03-31$50.74M
2020-12-31$77.62M
2020-09-30$40.3M
2020-06-30$29.56M
2020-03-31-$3.22M
2019-12-31-$32.06M
2019-09-30-$24.54M
2019-06-30-$13.98M
2019-03-31$2.97M
2018-12-31-$71,000.00
2018-09-30-$25.47M
2018-06-30-$20.07M
2018-03-31-$23.71M
2017-12-31$125.93M
2017-09-30$8.08M
2017-06-30-$25.48M
2017-03-31-$27.53M
2016-12-31-$22.58M
2016-09-30-$22.74M
2016-06-30-$21.72M
2016-03-31-$16.17M
2015-12-31$5.47M
2015-09-30-$23.24M
2015-06-30$4.23M
2015-03-31-$13.91M
2014-12-31-$3.85M
2014-09-30-$19.03M
2014-06-30-$14.94M
2014-03-31-$25.22M
2013-12-31-$21.32M
2013-09-30-$18.49M
2013-06-30-$22.12M
2013-03-31-$18.5M
2012-12-31-$4.41M
2012-09-30-$20.03M
2012-06-30-$14.05M
2012-03-31-$15.14M
2011-12-31-$18.43M
2011-09-30$5.15M
2011-06-30$3.1M
2011-03-31-$9.66M
2010-12-31-$17.88M
2010-09-30-$12.43M
2010-06-30-$12.15M

Annual Operating Income

DateOperating Income
2025-12-31$469.01M
2024-12-31$551.48M
2023-12-31$337.57M
2022-12-31$267.53M
2021-12-31$275.9M
2020-12-31$144.26M
2019-12-31-$67.61M
2018-12-31-$69.33M
2017-12-31$81M
2016-12-31-$83.21M
2015-12-31-$27.45M
2014-12-31-$63.04M
2013-12-31-$80.43M
2012-12-31-$53.63M
2011-12-31-$19.84M
2010-12-31-$54.26M
2009-12-31-$58.46M